CDRH's Innovation Pathway: A Quicker Route For Breakthrough Devices?

For a select few devices per year, FDA says it will speed up pre-market development times by intensifying staff efforts, with a particular focus on very early-stage, frequent interactions with product sponsors.

More from Archive

More from Medtech Insight